외과용 드레싱 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Surgical Dressing Market Size, Share & Trends Analysis By Product, By Application, By End Use (Hospital, Specialty Clinics, Home Healthcare, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

외과용 드레싱 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 외과용 드레싱 시장 규모는 2030년에 74억 달러에 달할 것으로 예측되며, 2023-2030년 CAGR 5.6%로 확대할 전망입니다. 그 배경에는 장기 이식 증가가 있습니다. 예를 들어 HRSA에 따르면 2021년에 40,000건 이상의 장기 이식이 이루어졌다고 합니다. 마찬가지로 Global Observatory on Donation and Transplantation에 따르면 2020년 세계에서 129,681개의 장기가 이식되어 산업 성장을 촉진하고 있습니다.

또한 외래수술센터(ASC) 증가와 외래수술센터(ASC)의 수술 증가는 사업 규모의 성장을 더욱 촉진하고 있습니다. 예를 들어 Health Capital에 따르면 1995년 1,340만 건이었던 수술 건수가 2020년에는 약 2,300만 건에 달했습니다. 또한 Agency for Healthcare Research &Quality에 따르면 ASC 수술 건수가 크게 증가하고 있습니다. 또한 유사한 출처에 따르면 외래 서비스는 2018년지역 병원 매출의 49%를 차지했습니다. 따라서 시장 성장을 가속하고 있습니다.

생활습관병 증가로 인한 수술 건수 증가는 시장 성장을 더욱 촉진할 것으로 예상됩니다. 예를 들어 영국 심장 재단에 따르면 2020년 영국에서 371,000건의 심장 수술이 실시되었습니다. 또한 Surgery for Obesity and Related Diseases에 따르면 2018년에 시행된 대사 및 비만 수술 건수는 10.80% 증가했습니다.

또한 COVID-19 환자 수의 감소는 가까운 시일 내에 이 제품에 대한 수요를 증가시킬 것으로 예상됩니다. 기업은 포스트 팬데믹 시장을 확보하기 위해 제휴, 합병, 판매 계약 등 다양한 전략을 선택하고 있습니다. 예를 들어 2021년 12월 Medline은 리치몬드 힐 물류 센터에 15억 달러를 투자하여 헬스케어 공급망을 강화했습니다. 메드라인은 2021년에 5곳의 물류센터를 새로 오픈하고 2022년에 2곳의 물류센터가 추가로 완공될 예정입니다. 따라서 이러한 사례가 예측 기간 중 시장을 촉진할 것으로 예상됩니다.

수술용 드레싱 시장 보고서 하이라이트

• 제품별로는 1차 드레싱이 2022년 43.6%로 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 그 배경에는 세계 수술 건수 증가와 상처 유병률 증가가 있습니다.
• 용도별로는 심혈관 관련 수술이 예측 기간 중 CAGR 6.2%로 가장 빠른 성장률을 보일 것으로 예상됩니다. 이는 세계 심혈관 수술 증가에 기인합니다.
• 최종 용도별로는 병원 부문이 2022년 가장 큰 점유율을 차지했지만, 외래수술센터(ASC) 부문은 2023-2030년 연평균 6.4%의 성장률을 나타낼 것으로 예상됩니다. 이는 ASC에서 진행되는 수술 건수 증가와 ASC의 수 증가에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 외과용 붕대 시장 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 보급과 성장 전망 매핑
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 억제요인 분석
• 문합 장비 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 외과용 붕대 시장 : 제품 추정·동향 분석

• 외과용 붕대 시장 주요 포인트
• 외과용 붕대 시장 : 제품과 서비스의 동향과 시장 점유율 분석, 2022년과 2030년
• 1차 드레싱
• 2차 드레싱
• 기타

제5장 외과용 붕대 시장 : 애플리케이션 추정·동향 분석

• 외과용 붕대 시장 주요 포인트
• 외과용 붕대 시장 : 애플리케이션 동향과 시장 점유율 분석, 2022년 및 2030년
• 당뇨병에 기반한 수술
• 심혈관질환
• 궤양
• 화상
• 이식 부위
• 기타

제6장 외과용 붕대 시장 : 최종 용도 추정·동향 분석

• 외과용 붕대 시장 주요 포인트
• 외과용 붕대 시장 : 최종 용도의 동향과 시장 점유율 분석, 2022년 및 2030년
• 병원
• 전문 클리닉
• 홈헬스케어
• 외래 수술 센터
• 기타

제7장 외과용 붕대 시장 : 지역 추정·동향 분석

• 지역별 전망
• 지역별 외과용 붕대 시장 : 주요 마켓플레이스 요점
• 북미
  • 북미 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 유럽 시장 추산·예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 스웨덴
  • 노르웨이
  • 덴마크
• 아시아태평양
  • 아시아태평양 시장 추산·예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 라틴아메리카 시장 추산·예측, 2018-2030년
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • MEA 시장 추산·예측, 2018-2030년
  • 사우디아라비아
  • 남아프리카공화국
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 시장 참여 기업의 분류
  • 3M
  • Smith & Nephew
  • Molnlycke Health Care AB
  • ConvaTec Group PLC
  • Johnson & Johnson Private Limited
  • Baxter
  • Coloplast Corp
  • Medtronic
  • Derma Sciences Inc.(Integra LifeSciences)
  • Cardinal Health

KSA

영문 목차

영문목차

Surgical Dressing Market Growth & Trends:

The global surgical dressing market size is anticipated to reach USD 7.40 billion in 2030 and is expected to expand at a CAGR of 5.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. This can be attributed to the rising incidence of organ transplants. For instance, as per HRSA, 40,000+ organ transplants were performed in 2021. Similarly, according to Global Observatory on Donation and Transplantation, 129,681 organs were transplanted globally in the year 2020, thereby boosting the industry growth.

Moreover, the increase in the number of ambulatory surgical centers & rise in surgical procedures at ambulatory surgical centers is further impelling growth in the business scale. For instance, according to Health Capital, around 23 million procedures were performed in 2020 as compared to 13.4 million in 1995. Further, as per Agency for Healthcare Research & Quality, the volume of surgeries performed in ASCs has grown considerably. Additionally, as per a similar source, the outpatient service accounted for 49% of community hospital revenue in 2018. Therefore, impelling the market growth.

The rising number of surgical procedures due to increasing lifestyle disorders is anticipated to further boost the market growth. For instance, as per British Heart Foundation, 371,000 heart procedures were carried out in England in 2020. Moreover, according to Surgery for Obesity and Related Diseases, there was an increase of 10.80% in the number of metabolic and bariatric procedures performed in 2018.

Furthermore, a decline in the number of COVID-19 patients is expected to boost the demand for the product in the near term. Companies are opting for various strategies such as partnerships, mergers, and distribution agreements, to capture the post-pandemic market. For instance, in December 2021, Medline enhanced the healthcare supply chain with an investment of USD 1.5 billion in the Richmond Hill distribution center. Medline opened 5 new distribution centers in 2021, whereas, two more distribution centers are projected for completion in the year 2022. Therefore, such instances are expected to drive the market over the forecast period.

Surgical Dressing Market Report Highlights:

• In terms of product, primary dressing is expected to hold the largest market share of 43.6% in 2022. This can be credited to the global increase in the number of surgeries and the rising prevalence of wounds
• Based on application, cardiovascular-related surgeries are projected to witness the fastest growth rate of CAGR of 6.2% during the forecast period. This can be attributed to rising cardiovascular surgeries worldwide
• Based on end-use, the hospitals segment held the largest share in 2022, whereas, the ambulatory surgical centers segment is anticipated to grow at a CAGR of 6.4% from 2023 to 2030. This can be credited to the rise in the number of surgeries performed in ASCs and the rising number of ASCs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Surgical Dressing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Anastomosis Devices Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Surgical Dressing Market: Product Estimates & Trend Analysis

• 4.1. Surgical Dressing Market Key Takeaways
• 4.2. Surgical Dressing Market: Product & Services Movement & Market Share Analysis, 2022 & 2030
• 4.3. Primary Dressing
  • 4.3.1. Primary dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.2. Foam dressing
    • 4.3.2.1. Foam dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.3. Alginate dressing
    • 4.3.3.1. Alginate dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.4. Soft silicone dressing
    • 4.3.4.1. Soft silicone dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.5. Composite dressing
    • 4.3.5.1. Composite dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.6. Hydrogel dressing
    • 4.3.6.1. Hydrogel dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.7. Hydrocolloid dressing
    • 4.3.7.1. Hydrocolloid dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.3.8. Film dressing
    • 4.3.8.1. Film dressing market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Secondary Dressing
  • 4.4.1. Secondary dressing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. Absorbents
    • 4.4.2.1. Absorbents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Bandages
    • 4.4.3.1. Bandages market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.2. Muslin bandage rolls
    • 4.4.3.2.1 Muslin bandage rolls market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.3. Elastic bandage rolls
    • 4.4.3.3.1 Elastic bandage rolls market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.4. Triangular bandages
    • 4.4.3.4.1 Triangular bandages market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.5. Orthopedic bandages
    • 4.4.3.5.1 Orthopedic bandages market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.6. Elastic plaster bandages
    • 4.4.3.6.1 Elastic plaster bandages market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3.7. Other bandages
    • 4.4.3.7.1 Other bandages market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Adhesive tapes
    • 4.4.4.1. Adhesive tapes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.5. Protectives
    • 4.4.5.1. Protectives market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.6. Other secondary dressings
    • 4.4.6.1. Other secondary dressings market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Others
  • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Surgical Dressing Market: Application Estimates & Trend Analysis

• 5.1. Surgical Dressing Market Key Takeaways
• 5.2. Surgical Dressing Market: Application Movement & Market Share Analysis, 2022 & 2030
• 5.3. Diabetes Based Surgeries
  • 5.3.1. Diabetes based surgeries market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Cardiovascular Diseases
  • 5.4.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Ulcers
  • 5.5.1. Ulcers market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Burns
  • 5.6.1. Burns market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Transplant sites
  • 5.7.1. Transplant sites market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Surgical Dressing Market: End Use Estimates & Trend Analysis

• 6.1. Surgical Dressing Market Key Takeaways
• 6.2. Surgical Dressing Market: End Use Movement & Market Share Analysis, 2022 & 2030
• 6.3. Hospitals
  • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Specialty Clinics
  • 6.4.1. Specialty clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Home Healthcare
  • 6.5.1. Home healthcare market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Ambulatory Surgery Centers
  • 6.6.1. Ambulatory surgery centers market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Surgical Dressing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Surgical Dressing Market by Region: Key Marketplace Takeaway
• 7.3. North America
  • 7.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.4. Europe
  • 7.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.2. UK
    • 7.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.4. France
    • 7.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.9. Denmark
    • 7.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. China
    • 7.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. India
    • 7.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. MEA
  • 7.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. South Africa
    • 7.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. 3M
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Smith & Nephew
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Molnlycke Health Care AB
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. ConvaTec Group PLC
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Johnson & Johnson Private Limited
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Baxter
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Coloplast Corp
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Medtronic
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
  • 8.2.9. Derma Sciences Inc. (Integra LifeSciences)
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
  • 8.2.10. Cardinal Health
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking

관련자료